почта: bd@sidmexinovia.com
Телефон: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Главная >
Tysabri 300 mg Injection
Tysabri 300 mg Injection
Manufacturer/Marketed By : Biogen Idec Biotech India Pvt Ltd
$1068.52 $957.62
Tysabri 300 mg injection is a targeted monoclonal antibody designed to manage multiple sclerosis, a chronic condition affecting the central nervous system, as well as Crohn's disease, a type of...
Сворачиваемый текст идеально подходит для длинных текстов, таких как абзацы и описания. Это отличный способ предоставить людям больше информации, сохраняя при этом лаконичность макета. Вы можете связать текст с чем угодно, включая внешний веб-сайт или другую страницу. Вы можете настроить текстовое поле так, чтобы оно разворачивалось и сворачивалось при щелчке пользователя, позволяя ему прочитать больше или меньше информации.
Natalizumab 300 mg
Active Pharmaceutical Ingredient
Tysabri 300 mg Injection
1 068,52 $
957,62 $
Tysabri 300 mg injection is a targeted monoclonal antibody designed to manage multiple sclerosis, a chronic condition affecting the central nervous system, as well as Crohn's disease, a type of inflammatory bowel disorder, primarily in adults. This medication works by modulating the immune system, specifically inhibiting the action of certain immune cells that can cause harm to healthy tissue, thereby reducing inflammation and potentially preserving nerve function. While Tysabri can be effective in alleviating symptoms and improving the quality of life for patients with these conditions, it is crucial to note that its safety and effectiveness have not been evaluated in individuals under 18 years of age. Patients should also be aware of potential risks associated with the treatment, including the possibility of serious infections and other complications. As such, regular monitoring by healthcare professionals is essential during the course of therapy. By choosing Tysabri, patients may find a new avenue for managing their symptoms and enhancing their overall well-being. Always consult your healthcare provider for personalized advice and to ensure this treatment is appropriate for your specific condition.
Active Pharmaceutical Ingredient
Применение
• Tysabri 300 mg injection is utilized in the treatment of multiple sclerosis (MS), a neurological disorder that affects the central nervous system. This medication helps to reduce the frequency of relapses and slows the progression of disability in individuals diagnosed with MS. By targeting specific immune responses, Tysabri 300 mg injection aids in protecting nerve fibers from damage. Patients often experience improvements in their overall quality of life as a result of this treatment.
• Another important application of Tysabri 300 mg injection is in the management of Crohn's disease, a chronic inflammatory bowel condition. This medication works by modulating the immune system to decrease inflammation in the digestive tract. Patients receiving Tysabri 300 mg injection may see a reduction in symptoms such as abdominal pain and diarrhea. As a result, this treatment can contribute to a more manageable disease course for those affected by Crohn's disease.
• Tysabri 300 mg injection is also indicated for patients who have not responded adequately to other treatments for their conditions. It provides an alternative therapeutic option for individuals dealing with the complexities of both MS and Crohn's disease. By offering a different mechanism of action, Tysabri 300 mg injection can help those who need additional support in managing their symptoms. This flexibility makes it a valuable choice in personalized patient care.
• The administration of Tysabri 300 mg injection is typically part of a comprehensive treatment plan overseen by healthcare professionals. It is often used in conjunction with other therapies to optimize outcomes for patients. Regular monitoring and assessment are essential to ensure that the treatment is effective and to adjust the approach as necessary. This collaborative strategy helps maximize the benefits of Tysabri 300 mg injection for patients with MS and Crohn's disease.
Преимущества
Multiple sclerosis (MS) is a condition that affects the brain and spinal cord, characterized by the immune system mistakenly attacking the protective covering of nerves, known as myelin. This assault leads to a variety of symptoms including vision problems, pain, fatigue, and difficulties with coordination. Tysabri 300 mg Injection is designed to intervene by suppressing the immune system, thus slowing down the progression of the disease. Reducing inflammation around the damaged nerves helps halt further deterioration and stabilise the immune response. This medication also aids in enhancing muscle strength, thereby improving mobility and boosting patients' confidence, ultimately contributing to an improved quality of life.
Crohn's disease, on the other hand, is a type of inflammatory bowel disease (IBD) characterised by chronic inflammation anywhere along the digestive tract, from the mouth to the anus. In this condition, the immune system attacks the lining of the digestive tract, resulting in inflammation, ulceration, and thickening of the bowel wall. Tysabri 300 mg Injection functions by selectively binding to specific immune cells, preventing their migration across both the blood-brain barrier and the inflamed intestinal lining. This mechanism effectively reduces inflammation in the affected regions, offering relief from symptoms associated with Crohn's disease.
Побочные эффекты
As with any medication, Tysabri 300 mg Injection may elicit side effects, which typically resolve as your body acclimates to the treatment and do not necessitate immediate medical intervention. However, if these side effects persist or cause concern, it's advisable to seek guidance from your doctor for further evaluation and management.
Наиболее распространенные побочные эффекты
• Diarrhoea
• Vaginitis
• Rash
• Nose and throat infections
• Nausea
• Stomach area pain
Распространенные побочные эффекты
• Headache
• Feeling tired
• Urinary tract infection
• Joint pain
• Lung infection
• Depression
• Pain in your arms or legs
Как использовать
Tysabri Injection is typically administered intravenously in a hospital or clinic under the supervision of a doctor or nurse. Your healthcare provider will determine the appropriate timing for the injection, so it's important to adhere to their guidance. The dosage and frequency of administration depend on the specific condition being treated. Additionally, your doctor may recommend complementary medications as part of your overall treatment plan. It's essential to continue taking this medication for the duration prescribed by your healthcare provider.
Safety Advice
• Alcohol: It's a good idea to avoid alcohol while taking Natalizumab Injection 300 mg as it can potentially interfere with the effectiveness of the medicine and increase the likelihood of side effects. Before consuming alcohol, it's best to talk to your doctor or pharmacist for personalised advice on whether it's safe to do so in conjunction with your treatment.
• Kidney: Patients with kidney disease should exercise caution when using Tysabri 300 mg Injection. It's crucial for them to closely monitor their kidney function throughout treatment with MS Drug Tysabri, and promptly notify their doctor of any unusual symptoms or changes in liver function. Depending on the severity of kidney disease, the doctor may need to adjust the dosage accordingly for these patients.
• Breastfeeding: Breastfeeding while using Natalizumab Injection 300 mg is not advised due to the potential risks it poses to the infant. Tysabri 300 mg has the potential to transfer into breast milk, potentially causing harm to the baby. If you are currently breastfeeding and using MS Drug Tysabri, it's crucial to have a discussion with your doctor regarding the potential advantages and disadvantages of continuing breastfeeding. Your doctor will provide personalised guidance to assist you in making the most suitable decision for the well-being of both you and your baby.
• Liver: Patients with liver disease should use Tysabri 300 mg Vial with caution. They need to monitor their liver function closely while taking Tysabri 300 mg and report any unusual symptoms or changes to their doctor immediately. Depending on the severity of your liver condition, dosage adjustments may be necessary, and this decision should be made in consultation with your healthcare provider.
• Pregnancy: The use of Tysabri 300 mg during pregnancy may be associated with risks, as animal studies suggest potential harm to the developing foetus. Therefore, if you are currently pregnant or considering becoming pregnant, it's important to discuss with your doctor the potential implications of using Natalizumab Injection 300 mg during this time. Your doctor will be able to give you an insight into the risks and benefits and help you make an informed decision that prioritises both your wellbeing and the health of your baby.
• Driving: Using Tysabri 300 mg Injection might result in experiences of dizziness, fatigue, and challenges with concentration and coordination, potentially compromising your capability to operate a vehicle safely. It's crucial to adhere to your physician's guidance meticulously and adopt appropriate measures, including refraining from driving or handling heavy machinery, particularly if you're experiencing any adverse effects from this Natalizumab Injection 300 mg.
Отказ от ответственности
Компания Sidmex Inovia стремится предоставлять точную и достоверную информацию; однако весь контент на этом веб-сайте, включая описания и состав продуктов, предназначен только для информационных целей и не должен рассматриваться как замена профессиональной медицинской консультации, диагностики или лечения.
Пользователям рекомендуется проконсультироваться с квалифицированным медицинским специалистом, прежде чем принимать какие-либо медицинские решения. Предоставленная информация не должна использоваться для самодиагностики или самолечения.
Все перечисленные продукты предназначены исключительно для B2B и оптовых запросов. Sidmex Inovia не пропагандирует прямое использование потребителями и стремится поддерживать, а не заменять отношения между медицинским работником и пациентом.
Названия продуктов, товарные знаки и бренды принадлежат их соответствующим владельцам, и их использование не подразумевает какой-либо связи или одобрения. Sidmex Inovia не несет ответственности за любые последствия, возникающие в результате использования информации, предоставленной на этом веб-сайте.